[Current issues in antiviral therapy of chronic hepatitis B and C].
The article represented the prevalence of chronic hepatitis B and chronic hepatitis C in our country and in the whole world, the modern approaches to the antiviral therapy, the diagnostic algorithms in the assessment of indications and contraindications to the antiviral therapy. There is a modern view on the unsolved problems of the antiviral therapy in such patients.
Bakulin
I G
IG
D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis; D019694:Hepatitis B, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D012426:Russia / Q000453:epidemiology; D014766:Viremia / Q000097:blood
D000998:Antiviral Agents; D015415:Biomarkers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a